Wolverine Blend 5mg/5mg

Description

Wolverine Blend 5mg/5mg is a two-component research blend combining BPC-157 (5mg) and Thymosin Beta 4 / TB-500 (5mg) — the two most studied peptides in repair biology research. This combination is designed to simultaneously engage the vascular/mucosal repair pathway (BPC-157) and the cytoskeletal migration/remodeling pathway (TB-500) within a single protocol.

Component Roles

• BPC-157 (5mg): 15-AA gastric pentadecapeptide studied for angiogenesis promotion, nitric oxide synthase modulation, fibroblast migration, and gut mucosal protection. Demonstrates repair pathway activity even in the presence of pro-inflammatory cytokines.
• TB-500 (5mg): Thymosin Beta 4 — 43-AA actin-sequestering peptide that maintains G-actin pools, drives cell migration via ILK/PI3K/Akt signaling, promotes angiogenesis, and has been studied in cardiac progenitor cell activation and tendon repair models.

Why This Combination

BPC-157 and TB-500 are the most commonly co-studied repair peptides because their mechanisms are complementary rather than redundant: BPC-157 focuses on vascular tube formation and mucosal integrity, while TB-500 drives the cellular migration required for wound closure and tissue remodeling. Together they cover both the vascular and cellular phases of the proliferative stage of repair. The 5mg/5mg format suits preliminary dose-finding and pilot in vitro studies.

Common Research Applications

• Combined vascular and cellular repair pathway investigation
• Wound healing, tendon, and musculoskeletal tissue repair models
• Angiogenesis + cell migration dual-mechanism studies
• BPC-157/TB-500 combination dosing characterization

For Research Use Only. Not for human or veterinary use.